Small coronary vessel angioplasty: Outcomes and technical considerations

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 915-922

  Rathore, Sudhir ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Coronary artery disease; Drug eluting stent; Restenosis; Small coronary arteries; Stent

Indexed keywords

ANTITHROMBOCYTIC AGENT; EVEROLIMUS; HEPARIN; PACLITAXEL; PHOSPHORYLCHOLINE; RAPAMYCIN; SILICON CARBIDE; UMIROLIMUS; ZOTAROLIMUS; DRUG DERIVATIVE;

ADVERSE OUTCOME; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; BARE METAL STENT; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; DRUG ELUTING STENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MATERIAL COATING; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL PARAMETERS; REVIEW; RISK REDUCTION; STENT STRUT THICKNESS; STENT THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; CORONARY BLOOD VESSEL; DRUG EFFECT; METHODOLOGY; STENT; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; HUMANS; PACLITAXEL; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 79952063010     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S8161     Document Type: Review

References (55)

1. Mackay J, Menash G. The Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organisation, Centers for disease control and prevention; 2004.
2. Wong P, Lau KW, Lim YL, Oesterele SN. Stent placement for non- STRESS/BENESTENT lesions: a critical review. Catheter Cardiovasc Interv. 2000;51:223-233.
3. O'Connor NJ, Morton JR, Birmeyer JD, Olmstead EM, O'Connor GT; Northern New England Cardiovascular Disease Study Group. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Circulation. 1996;93:652-655.
4. Bauters C, Hubert E, Prat A, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol. 1998;31:1291-1298.
5. Serruys PW, Kay IP, Disco C, et al. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta analysis of the Belgian Netherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter ultrasound stent in coronaries. J Am Coll Cardiol. 1999;34:1067-1074.
6. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon- expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489-495.
7. Fischman DL, Leon MB, Baim DS, et al. A randomised comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Eng J Med. 1994;331:496-501.
8. Macaya C, Serruys PW, Ruygrok P, et al. Continued benefit of coronary stenting versus balloon angioplasty: one year clinical follow up of Benestent Study Group. J Am Coll Cardiol. 1996;27:255-261.
9. Betriu A, Masotti M, Sera A, et al. Randomised comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J Am Coll Cardiol. 1999;34:1498-1506.
10. Keimeneij F, Serruys PW, Macaya C, et al. Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow up of Benestent-I trial. J Am Coll Cardiol. 2001;37:1598-1603.
11. Kastrati A, Schomig A, Dirschinger J, et al. A randomised trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary stenting or angioplasty for restenosis reduction in small arteries. Circulation. 2000;102:2593-2598.
12. Park SW, Lee CW, Hong MK, et al. Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries. Eur Heart J. 2000;21:1785-1789.
13. Koning R, Eltchaninoff H, Commeau P, et al. Stent placement compared with balloon angioplasty for small coronary arteries: in-hospital and 6-month clinical and angiographic results. Circulation. 2001;104: 1604-1608.
14. Moer R, Myreng Y, Molstad P, et al. Stenting in small coronary arteries (SISCA) trial. A randomised comparison between balloon angioplasty and the heparin-coated stent. J Am Coll Cardiol. 2001;38: 1598-1603.
15. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005;111: 3435-3442.
16. Meir B, Sousa E, Guagliumi G, et al. Sirolimus-eluting coronary stents in small vessels. Am Heart J. 2006; 151:1017el-1019e1
17. Ellis SG, Popma JJ, Lasala JM, et al. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005;45:1193-1200.
18. Agostoni P, Biondi-Zoccai GL, Gasparani GL, et al. Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomised trials. Eur Heart J. 2005;26:881-889.
19. Doucet C, Schalij MJ, Vrolix MC, et al. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation. 2001;104:2029-2033.
20. Haude M, Konorza TF, Kalnins U, Erglis A, et al. Heparin-coated stent placement for the treatment of stenosis in small coronary arteries of symptomatic patients. Circulation. 2003;107:1265-1270.
21. Kinsara AJ, Niazi K, Patel I, Amoudi O. Effectiveness of stents in small coronary arteries. Am J Cardiol. 2003;92:584-587.
22. Hanekamp C, Koolen J, Bonnier H, et al. Randomised comparison of balloon angioplasty versus silicon carbon-coated stent implantation for de novo lesions in small coronary arteries. Am J Cardiol. 2004;93:1233-1237.
23. Garcia E, Gomez-Reico M, Moreno R, et al. Stent reduces restenosis in small vessels. Results of the RAP study [abstract]. J Am Coll Cardiol. 2001;37:17A.
24. Muramatsu T, Iwasaki K, Inou N, et al. Efficacy of coronary stenting versus balloon angioplasty in vessels of diameter less than 3.0 mm and less than 2.5 mm: CHIVAS investigators [abstract]. Am J Cardiol. 2002; 90:96H.
25. Hausleiter J, Kastrati A, Mehelli J, et al. A randomised trial comparing phosphorylcholine-coated stents with balloon angioplasty in small coronary arteries in patients with symptomatic coronary artery disease. The ISAR-SMART 2 Trial [abstract]. Circulation. 2003;108:566-569.
26. Rodriguez AE, Rodriguez-Alemparte MJ, Pereira CF, et al. Final angiographic and clinical results of the Latin America small vessel randomised study (LASMAL trial) [abstract]. J AM Coll Cardiol. 2003; 41:26A.
27. Rodriguez A. LASMAL-II: a prospective randomised trial of phosphorylcholine- coated stenting vs balloon angioplasty in small vessels in the diabetic patient (featured lecture). TCT 2003. Available from: http://www.tctmd.com/expert-presentations. Accessed 2004 Jun 27.
28. Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004;109:1942-1947.
29. Stone GW, Ellis SG, Canon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomised controlled trial. JAMA. 2005;294:1215-1223.
30. Dawkins KD, Grube E, Guagliumi G, et al. Clinical efficacy of polymer- based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomised trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation. 2005;112:3306-3313.
31. Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomised trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004;109:634-640.
32. Popma JJ, Leon MB, Moses JW, et al. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation. 2004;110:3773-3780.
33. Ardissino D, Cavallini C, Bramucci E, et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomised trial. JAMA. 2004;292:2727-2734.
34. Lee CW, Suh J, Lee SW, et al. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries. Catheter Cardiovasc Interv. 2007;69:821-825.
35. Fajadet J, Wijns W, Laarman GJ, et al. Randomised, double-blind, multicenter study of the Endeavor zotralimus-eluting phosphorylcholine- encapsulated stent for the treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II Trial. Circulation. 2006;114:798-806.
36. Mehilli J, Dibra A, Kastrati A, et al. Randomised trial of paclitaxelandsirolimus-eluting stents in small coronary vessels. Eur Heart J. 2006;27:260-266.
37. Togni M, Eber S, Widmer J, et al. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a sub-group analysis of the SIRTAX Trial. J Am Coll Cardiol. 2007;50:1123-1131.
38. Park KH, Park SW, Hong MK, et al. Comparison of the effectiveness of sirolimus- and paclitaxel-eluting stents for small coronary artery lesions. Catheter Cardiovasc Interv. 2006;67:589-594.
39. Rodriguez-Granillo GA, Valgimigli M, Garcia-Garcia HM, et al. Oneyear clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries. J Invasive Cardiol. 2005;17:409-412.
40. Tanimoto S, Daemen J, Tsuchida K, et al. Two-year clinical outcome after coronary stenting of small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries. Catheter Cardiovasc Interv. 2007;69:94-103.
41. Leon MB, Mauri L, Popma JJ, et al. A randomised comparison of the Endeavor zotrolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions: 12 month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol. 2010;55:543-554.
42. Stone GW, Rizve A, Newman W, et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med. 2010;162:1663-1664.
43. Wykrzykowska JJ, Serruys PW, Onuma Y, et al. Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimuseluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy. JACC Cardiovasc Interv. 2009;2:861-870.
44. Stone GW, Midei M, Newman W, et al. Randomised comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the clinical evaluation of the XIENCE V everolimuseluting coronary stent system in the treatment of patients with de novo native coronary artery lesions SPIRIT III trial. Circulation. 2009; 19:680-686.
45. Kandzari D, Leon MB, Popma JJ, et al. Comparison of zotralimus- eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomised controlled trial. ENDEAVOR III trial. J Am Coll Cardiol. 2006;48:2440-2447.
46. Mauri L, Orav EJ, Candia SC, et al. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomised trials. Circulation. 2005;112:2833-2839.
47. Briguori C, Sarais C, Pagnotta P, et al. In-stent restenosis in small coronary arteries: impact of strut thickness. J Am Coll Cardiol. 2002; 40:403-409.
48. Brambilla N, Morici N, Bedogni F, et al. Thin strut chrome-cobalt stent implantation for treatment of de-novo lesions in small coronary vessels: results of the RISCO Italian registry utilizing the Mini VISION coronary stent platform. J Cardiovasc Med (Hagerstown). 2009;10: 852-858.
49. Turco MA, Ormiston JA, Poma JJ, et al. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberte stent: 1-year results from the TAXUS ATLAS program. JACC Cardiovasc Interv. 2008;1:699-709.
50. Karrillon GJ, Morice MC, Benveniste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French multicenter registry. Circulation. 1996;94: 1519-1527.
51. Mak KH, Belli G, Ellis SG, et al. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol. 1996;27:494-503.
52. Moussa I, Di Mario C, Reimers B, et al. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without antocoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol. 1997;29:6-12.
53. Akiyama T, Moussa I, Reimers B, et al. Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol. 1998;32: 1610-1618.
54. Lau KW, Ding ZP, Sim LL, et al. Clinical and angiographic outcome after angiography-guided stent placement in small coronary vessels. Am Heart J. 2000;139:830-839.
55. Kastrati A, Dirschinger J, Boekstegers P, et al. Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients. Catheter Cardiovasc Interv. 2000;50:290-297.